المؤلفون: van Velzen, A.J. (Annelies J.), Uges, J.W.F. (Joris), Heijerman, H.G.M. (Harry), Arets, B.G.M. (Bert), Nuijsink, M. (Marianne), Wiel-Kooij, E.C. van der, van Maarseveen, E.M. (Erik), Zanten, G.A. (Gijsbert) van, Pullens, B. (Bas), Touw, D.J. (Daan), Janssens, H.M. (Hettie)

المصدر: British Journal of Clinical Pharmacology

مصطلحات موضوعية: children, Cystic fibrosis, inhaled antibiotics, mesh nebulizer, pharmacokinetics

وصف الملف: application/pdf

العلاقة: http://repub.eur.nl/pub/118062Test; urn:hdl:1765/118062

الإتاحة: https://doi.org/10.1111/bcp.13988Test
http://repub.eur.nl/pub/118062Test

المؤلفون: van Velzen, A.J., Uges, J.W.F., Heijerman, H.G.M., Arets, H.G., Nuijsink, M., van der Wiel-Kooij, E.C., van Maarseveen, E.M., van Zanten, G.A., Pullens, B., Touw, D.J., Janssens, H.M.

المصدر: Journal of Cystic Fibrosis ; volume 16, page S25-S26 ; ISSN 1569-1993

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health

الإتاحة: https://doi.org/10.1016/s1569-1993Test(17)30239-4
https://api.elsevier.com/content/article/PII:S1569199317302394?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1569199317302394?httpAccept=text/plainTest

المؤلفون: Van Velzen, A.J., Bos, A.C., Touw, D.J., Tiddens, H.A.W.M., Heijerman, H.G.M., Janssens, H.M.

المصدر: Van Velzen , A J , Bos , A C , Touw , D J , Tiddens , H A W M , Heijerman , H G M & Janssens , H M 2016 , ' Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization ' , Journal of aerosol medicine and pulmonary drug delivery , vol. 29 , no. 3 , pp. 273-280 . https://doi.org/10.1089/jamp.2015.1259Test

مصطلحات موضوعية: cystic fibrosis, inhaled therapy, nebulizer, small airways, adverse drug reaction, airway, clinical article, clinical trial, controlled clinical trial, crossover procedure, exposure, human, human tissue, maximum plasma concentration, medical nebulizer, minimum plasma concentration, pharmacokinetics, randomized controlled trial, safety, tobramycin

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/38f52772-c17a-4a6c-bc8a-57b6df4b0851Test

الإتاحة: https://doi.org/10.1089/jamp.2015.1259Test
https://hdl.handle.net/11370/38f52772-c17a-4a6c-bc8a-57b6df4b0851Test
https://research.rug.nl/en/publications/38f52772-c17a-4a6c-bc8a-57b6df4b0851Test
https://pure.rug.nl/ws/files/79345531/Pharmacokinetics_and_Tolerability_of_Once_Daily_Double_Dose_Tobramycin_Inhalation.pdfTest

المؤلفون: Van Velzen, A.J., Bos, A.C., Touw, D.J., Tiddens, H.A.W.M., Heijerman, H.G.M., Janssens, H.M.

المصدر: Van Velzen , A J , Bos , A C , Touw , D J , Tiddens , H A W M , Heijerman , H G M & Janssens , H M 2015 , ' Pharmacokinetics and safety of once daily double dose inhaled tobramycin administered with the controlledinhalation AKITA® and conventional PARI-LC® Plus nebulizer in cystic fibrosis ' , Journal of Cystic Fibrosis , vol. 14 , no. suppl. 1 , pp. S26 . https://doi.org/10.1016/S1569-1993Test(15)30083-7

مصطلحات موضوعية: tobramycin, cystic fibrosis, nebulizer, safety, European, pharmacokinetics, inhalation, patient, human, blood level, nebulization, lung infection, exposure, area under the curve, blood sampling, recommended drug dose, adult, crossover procedure, absorption, treatment outcome

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/0c318763-c5f0-4919-be02-25c7e7903cecTest

الإتاحة: https://doi.org/10.1016/S1569-1993Test(15)30083-7
https://hdl.handle.net/11370/0c318763-c5f0-4919-be02-25c7e7903cecTest
https://research.rug.nl/en/publications/0c318763-c5f0-4919-be02-25c7e7903cecTest
https://pure.rug.nl/ws/files/84878205/Pharmacokinetics_and_safety_of_once_daily_double_dose_inhaled_tobramycin.pdfTest

المؤلفون: Van Velzen, A.J., Uges, J.W.F., Arets, H.G.M., Nuijsink, M., Van Der Wiel-Kooij, E.C., Pullens, B., Heijerman, H.G.M., Touw, D.J., Janssens, H.M.

المصدر: Van Velzen , A J , Uges , J W F , Arets , H G M , Nuijsink , M , Van Der Wiel-Kooij , E C , Pullens , B , Heijerman , H G M , Touw , D J & Janssens , H M 2015 , ' Tobramycin nebulization with I-neb® in children with cystic fibrosis (TONI study) : Pharmacokinetics and safety ' , Journal of Cystic Fibrosis , vol. 14 , no. suppl. 1 , pp. S49 . https://doi.org/10.1016/S1569-1993Test(15)30158-2

مصطلحات موضوعية: tobramycin, aminoglycoside, antibiotic agent, cystic fibrosis, home nebulizer, child, human, nebulization, pharmacokinetics, safety, European, nebulizer, blood level, inhalation, patient, area under the curve, parameters, hearing test, toxicity, blood sampling, hearing, exposure, vitrification device

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/34f3ae31-a924-44b9-8604-195561812937Test

الإتاحة: https://doi.org/10.1016/S1569-1993Test(15)30158-2
https://hdl.handle.net/11370/34f3ae31-a924-44b9-8604-195561812937Test
https://research.rug.nl/en/publications/34f3ae31-a924-44b9-8604-195561812937Test
https://pure.rug.nl/ws/files/86307492/Tobramycin_nebulization_with_I_neb_in_children_with_cystic_fibrosis.pdfTest

المؤلفون: van Velzen, A.J., Uges, J.W.F., Le Brun, P.P.H., Shahbabai, P., Touw, D.J., Heijerman, H.G.M.

المساهمون: ALLM, NCFS, Mediq Romedic

المصدر: Journal of Cystic Fibrosis ; volume 14, issue 6, page 748-754 ; ISSN 1569-1993

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health

الإتاحة: https://doi.org/10.1016/j.jcf.2015.01.002Test
https://api.elsevier.com/content/article/PII:S1569199315000041?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1569199315000041?httpAccept=text/plainTest

المؤلفون: van Velzen, A.J., Uges, J.W.F., Arets, H.G.M., Nuijsink, M., van der Wiel-Kooij, E.C., Pullens, B., Heijerman, H.G.M., Touw, D.J., Janssens, H.M.

المصدر: Journal of Cystic Fibrosis ; volume 14, page S49 ; ISSN 1569-1993

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health

الإتاحة: https://doi.org/10.1016/s1569-1993Test(15)30158-2
https://api.elsevier.com/content/article/PII:S1569199315301582?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1569199315301582?httpAccept=text/plainTest

المؤلفون: van Velzen, A.J., Bos, A.C., Touw, D.J., Tiddens, H.A.W.M., Heijerman, H.G.M., Janssens, H.M.

المصدر: Journal of Cystic Fibrosis ; volume 14, page S26 ; ISSN 1569-1993

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health

الإتاحة: https://doi.org/10.1016/s1569-1993Test(15)30083-7
https://api.elsevier.com/content/article/PII:S1569199315300837?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1569199315300837?httpAccept=text/plainTest

المؤلفون: Van Velzen, A.J., Uges, J.W.F., Le Brun, P.P.H., Shahbabai, P., Touw, D.J., Heijerman, H.G.M.

المصدر: Journal of Cystic Fibrosis ; volume 13, page S30 ; ISSN 1569-1993

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health

الإتاحة: https://doi.org/10.1016/s1569-1993Test(14)60092-8
https://api.elsevier.com/content/article/PII:S1569199314600928?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1569199314600928?httpAccept=text/plainTest

المؤلفون: van Velzen, A.J., Berkhout, M.C., Touw, D.J., de Kok, B.M., Heijerman, H.G.M.

المصدر: Journal of Cystic Fibrosis ; volume 13, page S57 ; ISSN 1569-1993

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health

الإتاحة: https://doi.org/10.1016/s1569-1993Test(14)60178-8
https://api.elsevier.com/content/article/PII:S1569199314601788?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1569199314601788?httpAccept=text/plainTest